Clinical Trial Update: The Evaluation of FeNO for Predicting Response to ICS in Subjects With Non-specific Respiratory Symptoms [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating whether fractional exhaled nitric oxide (FeNO) can predict response to inhaled corticosteroids in subjects with asthma …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Inhaled corticosteroids (ICS)

Snippet

Sponsor: Research in Real-Life Ltd | Conditions: Asthma | Phase 4 | Status: COMPLETED